Cargando…

Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Detalles Bibliográficos
Autores principales: Ahmadi, Seyed Esmaeil, Rahimi, Samira, Zarandi, Bahman, Chegeni, Rouzbeh, Safa, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414674/
https://www.ncbi.nlm.nih.gov/pubmed/34474678
http://dx.doi.org/10.1186/s13045-021-01152-9
_version_ 1783747826926223360
author Ahmadi, Seyed Esmaeil
Rahimi, Samira
Zarandi, Bahman
Chegeni, Rouzbeh
Safa, Majid
author_facet Ahmadi, Seyed Esmaeil
Rahimi, Samira
Zarandi, Bahman
Chegeni, Rouzbeh
Safa, Majid
author_sort Ahmadi, Seyed Esmaeil
collection PubMed
description
format Online
Article
Text
id pubmed-8414674
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84146742021-09-09 Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies Ahmadi, Seyed Esmaeil Rahimi, Samira Zarandi, Bahman Chegeni, Rouzbeh Safa, Majid J Hematol Oncol Correction BioMed Central 2021-09-03 /pmc/articles/PMC8414674/ /pubmed/34474678 http://dx.doi.org/10.1186/s13045-021-01152-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Ahmadi, Seyed Esmaeil
Rahimi, Samira
Zarandi, Bahman
Chegeni, Rouzbeh
Safa, Majid
Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title_full Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title_fullStr Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title_full_unstemmed Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title_short Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
title_sort correction to: myc: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414674/
https://www.ncbi.nlm.nih.gov/pubmed/34474678
http://dx.doi.org/10.1186/s13045-021-01152-9
work_keys_str_mv AT ahmadiseyedesmaeil correctiontomycamultipurposeoncogenewithprognosticandtherapeuticimplicationsinbloodmalignancies
AT rahimisamira correctiontomycamultipurposeoncogenewithprognosticandtherapeuticimplicationsinbloodmalignancies
AT zarandibahman correctiontomycamultipurposeoncogenewithprognosticandtherapeuticimplicationsinbloodmalignancies
AT chegenirouzbeh correctiontomycamultipurposeoncogenewithprognosticandtherapeuticimplicationsinbloodmalignancies
AT safamajid correctiontomycamultipurposeoncogenewithprognosticandtherapeuticimplicationsinbloodmalignancies